Bal Pharma Limited has informed the Exchange regarding Notice of Postal Ballot
BALPHARMA · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Bal Pharma Limited has issued a Postal Ballot Notice seeking shareholder approval for the appointment of Mr. Ravindra Kumar Kothari (DIN: 03418320) as a Non-Executive and Non-Independent Director of the company. Mr. Kothari was initially appointed as an Additional Director by the Board on May 5, 2025, and is now being proposed for a 5-year term ending August 1, 2030, with his office liable to retire by rotation. He is a commerce graduate with 45 years of overall experience, including 12 years in the pharmaceutical industry, and currently holds directorships in Bal Research Foundation, Lifezen Healthcare Private Limited, and Balance Clinics LLP. His last drawn remuneration was Rs. 20.42 Lakhs per annum, and he holds 2,437 shares in the company. E-voting will be conducted from July 2, 2025 to July 31, 2025 via NSDL, with results to be announced on or before August 18, 2025.
This is a routine governance action to formalize a board appointment already made by the Board. No immediate material impact on shareholders or stock price is expected, as the appointment does not alter the company's operations or financial position.